Industrial Processes

Wired interview Andrey Zarur

1 month ago   |   By Green Light Biosciences

“Manufacturing enough Covid-19 vaccine is a logistical nightmare”
GreenLight CEO Andrey Zarur tells Wired:
“2,000 litre bioreactor might yield 100 times more vaccine than a similar volume of more conventional vaccines, which sometimes have to be grown in chicken eggs...The process have was really never designed to be an industrial, global scale process... [Vaccine manufacturers may struggle to get their hands on the raw materials, such as nucleotides, that go into the vaccines]...People are working hard to come up with ways to de-bottleneck those supply chains, but the reality is that the...
Read more ...

 


Search by Tags

   Industrial Processes      Industrial      RNA      Manufacturing      Vaccine      Nucleotide      Vaccines      Nucleotides      Blog  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Mail Online: Vaccine roll out issues

Mail Online: Vaccine roll out issues

GreenLight Biosciences explain to the Mail Online about the vaccine roll out issues for a Covid-19 vaccine. GreenLight Biosciences spoke to Mail Online about the vaccine supply... Read more ...

Primer on Carbon Dioxide Removal Provides Vital Resource at Critical Time

Primer on Carbon Dioxide Removal Provides Vital Resource at Critical Time

Berkeley Lab researchers are working on ways to sequester more carbon in soil, including through agricultural practices. Scientists say that any serious plan to address... Read more ...

A 1-Atom-Deep Look at a Water-Splitting Catalyst

A 1-Atom-Deep Look at a Water-Splitting Catalyst

This illustration shows two possible types of surface layers for a catalyst that performs the water-splitting reaction, the first step in making hydrogen fuel: The gray surface... Read more ...

New Research Technique Sheds Light on Least Understood Part of Lithium Batteries

New Research Technique Sheds Light on Least Understood Part of Lithium Batteries

A scientist works on the MALDI (matrix-assisted laser desorption/ionization) mass spectrometer at Berkeley Lab's Molecular Foundry. One of the aspects of lithium-ion batteries... Read more ...

Ozone Generators May Help Remediate Contamination Caused by Thirdhand Smoke

Ozone Generators May Help Remediate Contamination Caused by Thirdhand Smoke

Residue from cigarettes can linger on indoor surfaces for years and even decades. In 10 years of studying thirdhand smoke, which is the toxic cigarette residue that clings to... Read more ...

Financial Times: Get vaccine new variant ready

Financial Times: Get vaccine new variant ready

GreenLight Biosciences explain to the Financial Times how messenger RNA can help get the Covid-19 vaccine new variant ready. GreenLight Biosciences spoke to the Financial Times... Read more ...

Shine On: Avalanching Nanoparticles Break Barriers to Imaging Cells in Real Time

Shine On: Avalanching Nanoparticles Break Barriers to Imaging Cells in Real Time

From left: Experimental images of thulium-doped avalanching nanoparticles separated by 300 nanometers; at right, simulations of the same material. (Credit: Berkeley Lab and... Read more ...

NextCure hires Celgene vet as CMO; José Vega leaves Merck to become...

NextCure has found its new CMO after the previous executive resigned last August. Han Myint, a biopharma and academia veteran of more than 20 years, joined the company Thursday... Read more ...

Prometheus Biosciences: Director, Clinical Operations

Prometheus Biosciences: Director, Clinical Operations Company Description Pre-IPO, clinical stage biotech with lead asset in Ph 1 and potential for first-in-class mechani San... Read more ...

In LA, ambulances circle for hours and ICUs are full. Is this what Covid-19...

Do the overwhelmed hospitals in Los Angeles offer a glimpse of what other regions may soon face as case counts rise steeply and a seemingly more infectious strain takes hold?... Read more ...